Literature DB >> 16900357

Efficacy of plasmin enzymes and chondroitinase ABC in creating posterior vitreous separation in the pig: a masked, placebo-controlled in vivo study.

Martin Hermel1, Norbert F Schrage.   

Abstract

BACKGROUND: Induction of posterior vitreous detachment (PVD) during vitrectomy helps to prevent proliferative complications, but can be traumatic to the retina, particularly in young patients. Adjunct enzymes have been proposed to facilitate PVD. We investigated the efficacy of enzymes in creating PVD as an adjunct to vitrectomy in the pig.
METHODS: Five groups of 8 pigs received a masked intravitreal injection of chondroitinase (1 IU), human (0.4 or 1.3 activity units [AU]) or porcine plasmin (0.18 AU or 0.47 AU) into one eye, and osmolarity adjusted control into the other. After incubation, a core vitrectomy was performed on each eye at low suction, without vitreous peeling. The occurrence of spontaneous PVD and its extent were graded. Eyes were investigated using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Vitreous remnants on the retina were quantified in SEM. Data were analyzed using McNemar's test for paired observations and Wilcoxon paired signed rank test.
RESULTS: Spontaneous PVD occurred more frequently in human plasmin-treated eyes (p<0.025) and all plasmin eyes (p<0.025) than in placebo controls. The extent of PVD appeared larger in human plasmin (p<0.025) and all plasmin-treated eyes (p<0.025). In plasmin-treated eyes, SEM morphometry showed a significant reduction in the vitreous-covered retina areas. Chondroitinase failed to produce an effect.
CONCLUSIONS: Plasmin may prove a useful adjunct to conventional vitrectomy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16900357     DOI: 10.1007/s00417-006-0388-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  40 in total

1.  Intrasurgical plasmin enzyme in diabetic macular edema.

Authors:  Claudio Azzolini; Armando D'Angelo; Gisella Maestranzi; Marco Codenotti; Patrizia Della Valle; Matteo Prati; Rosario Brancato
Journal:  Am J Ophthalmol       Date:  2004-10       Impact factor: 5.258

Review 2.  Pharmacologic vitreolysis.

Authors:  J Sebag
Journal:  Retina       Date:  1998       Impact factor: 4.256

3.  Drug distribution in the vitreous humor of the human eye: the effects of intravitreal injection position and volume.

Authors:  S Friedrich; Y L Cheng; B Saville
Journal:  Curr Eye Res       Date:  1997-07       Impact factor: 2.424

4.  Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane.

Authors:  L A Liotta; R H Goldfarb; R Brundage; G P Siegal; V Terranova; S Garbisa
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

5.  Posterior vitreous detachment with plasmin in the isolated human eye.

Authors:  Xiaoxin Li; Xuan Shi; Jingyu Fan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-01       Impact factor: 3.117

6.  Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase.

Authors:  M Harooni; T McMillan; M Refojo
Journal:  Retina       Date:  1998       Impact factor: 4.256

7.  Autologous plasmin enzyme in the surgical management of diabetic retinopathy.

Authors:  J G Williams; M T Trese; G A Williams; M K Hartzer
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

8.  Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous.

Authors:  T Hikichi; N Yanagiya; M Kado; J Akiba; A Yoshida
Journal:  Retina       Date:  1999       Impact factor: 4.256

9.  Chemical analysis of bovine and porcine vitreous humors: correlation of normal values with serum chemical values and changes with time and temperature.

Authors:  P S McLaughlin; B G McLaughlin
Journal:  Am J Vet Res       Date:  1987-03       Impact factor: 1.156

10.  The role of recombinant lysine-plasminogen and recombinant urokinase and sulfur hexafluoride combination in inducing posterior vitreous detachment.

Authors:  Gamze Men; Gholam A Peyman; Mahmoud Genaidy; Po-Cheng Kuo; Fatemah Ghahramani; Diane A Blake; Yanno Bezerra; Georges Naaman; Eduardo Figueiredo
Journal:  Retina       Date:  2004-04       Impact factor: 4.256

View more
  7 in total

1.  A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.

Authors:  Martin Hermel; Wendelin Dailey; Michael Trese; Michael K Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-03       Impact factor: 3.117

2.  Effect of intravitreal plasmin on vitreous removal through a 25-gauge cutting system in the rabbit in vivo.

Authors:  Martin Hermel; Jonathan Prenner; Motaz Alabdulrazzak; Wendy Dailey; Michael Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

3.  Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.

Authors:  Polly A Quiram; Victor R Leverenz; Robert M Baker; Loan Dang; Frauk J Giblin; Michael T Trese
Journal:  Retina       Date:  2007-10       Impact factor: 4.256

4.  Preservation of structure and immunoreactivity at the vitreoretinal interface of the rabbit eye.

Authors:  Bruce A Pfeffer; Steven A Bernstein; Stephen P Bartels
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-20       Impact factor: 3.117

5.  Emerging nonsurgical methods for the treatment of vitreomacular adhesion: a review.

Authors:  Eric W Schneider; Mark W Johnson
Journal:  Clin Ophthalmol       Date:  2011-08-18

6.  Pharmacologic vitreolysis.

Authors:  Hossein Nazari; Mehdi Modarres-Zadeh; Arash Maleki
Journal:  J Ophthalmic Vis Res       Date:  2010-01

Review 7.  Ocriplasmin: who is the best candidate?

Authors:  Claudia M Prospero Ponce; William Stevenson; Rachel Gelman; Daniel R Agarwal; John B Christoforidis
Journal:  Clin Ophthalmol       Date:  2016-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.